NED Labs

CURING CANCER, ONE PATIENT AT A TIME

No Evidence of Disease

An individualized cancer treatment and learning program, built around one patient.

NO EVIDENCE OF DISEASE

CONTINUOUS MEASUREMENT·HOURLY · DAILY · WEEKLY

Oncology at a different pace.

For cancer patients, every minute counts. Fast design of personal n=1 clinical trials, according to the latest science, with intensive measurements to find out what works.

THE PROBLEM

Three gaps stand between
patients and what might work.

NED closes all three

Time

MRI scans usually come 3 months apart. If a therapy isn't working, it can take 3 to 6 months to spot. Time patients often can't afford.

Access

Promising new treatments are scattered across fields and countries, each in its own silo. A new finding can take 15 to 20 years to travel from the lab to patients.

Execution

Running a complex treatment protocol is a full-time job. Running several at once is more than any family can carry alone.

A NETWORK THAT WORKS FOR YOU

NED Alliance

Leading physicians and researchers from top institutions, working on one patient together.

MEMBERS

Oncology, genomics, imaging, metabolism and more

FOUNDER

Eran Glicksman

Founder & CEO

Co-founder and former CTO, Masterschool

EVIDENCE-BASED MEDICINE

Prof. Gordon Guyatt, MD

Physician & Professor, McMaster University

Coined “evidence-based medicine”

NEURO-ONCOLOGY

Prof. Deborah Blumenthal, MD

Director of Neuro-Oncology

Tel Aviv Sourasky Medical Center

CELL THERAPY

Dr. Ari Raphael, MD

Head of Translational Oncology

Davidoff Cancer Center

CANCER BIOLOGY

Prof. Giulio Draetta, MD, PhD

Former Chief Scientific Officer

MD Anderson

IMAGING PHYSICS

Prof. Matthew Rosen, PhD

Director, Low-Field MRI Lab

Martinos Center (MGH/Harvard)

GENOMICS

Prof. Noam Shomron, PhD

Head, Functional Genomics Laboratory

Tel Aviv University

METABOLIC THERAPY

Dr. Tomas Duraj, MD, PhD

Metabolic cancer therapy researcher

Seyfried Lab, Boston College

SOCIAL GENOMICS

Prof. Steve Cole, PhD

Social genomics researcher

UCLA

SENSING TECH

Mark Popov

Chief Platform Innovation Officer

Vayyar Imaging

THORACIC ONCOLOGY

Dr. Barliz Waissengrin, MD

Thoracic oncologist

Cedars-Sinai, Beverly Hills, CA

NEUROIMAGING

Dr. Daniel Barazany

Manager, Human MRI Unit

Strauss Center for Computational Neuroimaging, Tel Aviv University

OUR FIRST PATIENT

The first 16 weeks

Five years ago, our first patient was diagnosed with brain cancer and given a terminal prognosis. They started searching for treatment on their own, and found what determined patients often find: promising options exist, but no one can research, coordinate and carry them all out alone.

We joined forces.

RESULTS AFTER 16 WEEKS

Before NED, the tumor grew every quarter, faster and faster.
With NED, growth slowed, then stopped.

Tumor volume, indexed to December 2024. Quarterly growth rates from MRI before NED; weekly MRI since June 2026.

−17%

Tumor metabolic activity

BEFORE NED

100%

WITH NED

83%

With steady low glucose, high ketones, better sleep and lower inflammation.

68 days

Without a seizure

BEFORE NED

~14 d

WITH NED

68 d

Previously about one every 14 days (as of Sep 24, 2026).

More MRI scans

16 MRI scans in 16 weeks, against 2 in usual care. We see what's working, and what isn't, much sooner.

Early results from one patient, not proof of efficacy. We keep adapting until we reach NED: No Evidence of Disease.

HOW WE WORK

Everything a patient needs, in one team.

Healing is the patient's job. Everything else is ours.

01 / 04

Research

A dedicated research team builds an in-depth patient profile from medical records and comprehensive measurement. They map promising therapeutic options available worldwide.

OncologyImmunologyGeneticsMetabolismImagingCell therapy

02 / 04

Expert network

Instead of one novel treatment at one facility, we combine all chosen options into one protocol. Our network gives patients access to the best minds in the field, without the months of calls and referrals it takes to reach them alone. If the right expert is not in it yet, we reach them.

03 / 04

Rapid measurement

Highly frequent, comprehensive data collection lets us rapidly identify treatment effects: what is working and what is not. Then we adapt the treatment.

USUAL CARE · 16 WEEKS

MRI SCANS2scans

BLOOD PANELS2as needed

CONTINUOUSLY0

No continuous measurement, usually.

WELLBEING0

Rarely tracked.

WITH NED · 16 WEEKS

MRI SCANS16scans

BLOOD PANELS16panels

CONTINUOUSLY24/7

Metabolic markers, sleep and activity, nutrition intake.

WELLBEING112daily check-ins

Wellbeing and symptom tracking.

Weekly MRI & MRS scansSafety panel: liver, kidneysMetabolic panelImmune indicatorsGlucose & ketone sensorsSleep & activitySunlightVideo food logPersonal nutrition plan

04 / 04

Effective operations

Physicians, tests, medicines, nutrition, travel, scheduling, shipping and all operations, run by one team. A plan only matters if it happens. We make it happen.

Everything around the patient, coordinated by one team.

THE FEEDBACK LOOP

Treatment adapted in weeks, not months.

We treat, measure, interpret and adapt the treatment. Then the loop starts again.

THE INVERSION

Find what heals one patient, not the average.

Standard research tests one intervention on thousands of people to learn what works on average. NED Labs tests many interventions on one patient, measured meticulously, to learn what works for them. And every answer makes the next patient's program smarter.

Standard researchONE INTERVENTION

One average answer

thousands of patients · years

INVERT

NED LabsONE PATIENT

Many interventions, measured

formal n-of-1 studies

Every minute counts.

Help us find what works, faster. Write to us.